Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2007 1
2009 2
2010 2
2011 3
2012 2
2013 10
2014 3
2015 1
2016 3
2017 4
2018 4
2019 2
2020 4
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Retraction.
Brand TM, Iida M, Corrigan KL, Braverman CM, Coan JP, Flanigan BG, Stein AP, Salgia R, Rolff J, Kimple RJ, Wheeler DL. Brand TM, et al. Among authors: iida m. Sci Signal. 2021 Nov 9;14(708):eabn0168. doi: 10.1126/scisignal.abn0168. Epub 2021 Nov 9. Sci Signal. 2021. PMID: 34752142 Free PMC article. No abstract available.
Adaptive responses to antibody based therapy.
Rodems TS, Iida M, Brand TM, Pearson HE, Orbuch RA, Flanigan BG, Wheeler DL. Rodems TS, et al. Among authors: iida m. Semin Cell Dev Biol. 2016 Feb;50:153-63. doi: 10.1016/j.semcdb.2016.01.001. Epub 2016 Jan 22. Semin Cell Dev Biol. 2016. PMID: 26808665 Review.
Nuclear EGFR as a molecular target in cancer.
Brand TM, Iida M, Luthar N, Starr MM, Huppert EJ, Wheeler DL. Brand TM, et al. Among authors: iida m. Radiother Oncol. 2013 Sep;108(3):370-7. doi: 10.1016/j.radonc.2013.06.010. Epub 2013 Jul 3. Radiother Oncol. 2013. PMID: 23830194 Free PMC article. Review.
The role of Src in solid tumors.
Wheeler DL, Iida M, Dunn EF. Wheeler DL, et al. Among authors: iida m. Oncologist. 2009 Jul;14(7):667-78. doi: 10.1634/theoncologist.2009-0009. Epub 2009 Jul 6. Oncologist. 2009. PMID: 19581523 Free PMC article. Review.
Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol.
Pearson HE, Iida M, Orbuch RA, McDaniel NK, Nickel KP, Kimple RJ, Arbiser JL, Wheeler DL. Pearson HE, et al. Among authors: iida m. Mol Cancer Ther. 2018 Jan;17(1):204-214. doi: 10.1158/1535-7163.MCT-17-0384. Epub 2017 Oct 20. Mol Cancer Ther. 2018. PMID: 29054984 Free PMC article.
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.
McDaniel NK, Cummings CT, Iida M, Hülse J, Pearson HE, Vasileiadi E, Parker RE, Orbuch RA, Ondracek OJ, Welke NB, Kang GH, Davies KD, Wang X, Frye SV, Earp HS, Harari PM, Kimple RJ, DeRyckere D, Graham DK, Wheeler DL. McDaniel NK, et al. Among authors: iida m. Mol Cancer Ther. 2018 Nov;17(11):2297-2308. doi: 10.1158/1535-7163.MCT-17-1239. Epub 2018 Aug 9. Mol Cancer Ther. 2018. PMID: 30093568 Free PMC article.
45 results